Muguruma Kazuki, Takahashi Tetsuya, Tagane Yuichiro, Nazere Keyoumu, Hara Naoyuki, Nakamori Masahiro, Yamazaki Yu, Morino Hiroyuki, Maruyama Hirofumi
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima-shi, Hiroshima, 734-8551, Japan.
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima-shi, Hiroshima, 734-8551, Japan; Department of Rehabilitation, Faculty of Rehabilitation, Hiroshima International University, 555-36 Kurose Gakuendai, Higashihiroshima-shi, Hiroshima, 739-2695, Japan; Department of Neurology, MNES Inc., 1-2-27 Shinonomehonmachi, Minami-ku, Hiroshima-shi, Hiroshima, 734-0023, Japan.
Biochem Biophys Res Commun. 2025 Apr 9;757:151605. doi: 10.1016/j.bbrc.2025.151605. Epub 2025 Mar 7.
Tau protein aggregation plays an important role in the pathophysiology of neurodegenerative diseases, including Alzheimer's disease and Niemann-Pick disease type C. Liquid-liquid phase separation has emerged as a key mechanism in the early stages of protein aggregation for these disorders. Tau protein incubated with heparin undergoes liquid-liquid phase separation to form liquid droplets in vitro. However, whether tau liquid droplet formation occurs in vivo remains unresolved. To investigate cellular conditions that promote tau droplet formation, we treated tau-expressing human embryonic kidney 293T cells with reagents that introduced anionic substances or induced intracellular vesicle accumulation. Suppression of Niemann-Pick disease type C1 protein, a lysosomal membrane protein involved in mediating intracellular cholesterol trafficking, or the introduction of negatively charged dextran into cultured cells, increased the formation of tau-positive puncta with liquid droplet characteristics in a concentration-dependent manner. After prolonged observation, these puncta transitioned from a dynamic liquid state to a more solid-like gel phase, indicating progressive aggregation. Our findings suggest that intracellular enrichment of negatively charged substances or vesicles induces tau phase separation, potentially contributing to its pathological aggregation. These results provide insight into the molecular mechanisms underlying tauopathies and highlight potential targets for therapeutic intervention.
tau蛋白聚集在神经退行性疾病的病理生理学中起重要作用,包括阿尔茨海默病和C型尼曼-匹克病。液-液相分离已成为这些疾病蛋白质聚集早期阶段的关键机制。与肝素一起孵育的tau蛋白在体外会发生液-液相分离形成液滴。然而,tau液滴在体内是否形成仍未解决。为了研究促进tau液滴形成的细胞条件,我们用引入阴离子物质或诱导细胞内囊泡积累的试剂处理表达tau的人胚肾293T细胞。抑制参与介导细胞内胆固醇转运的溶酶体膜蛋白C型尼曼-匹克病1蛋白,或将带负电荷的葡聚糖引入培养细胞,会以浓度依赖的方式增加具有液滴特征的tau阳性斑点的形成。经过长时间观察,这些斑点从动态液态转变为更类似固体的凝胶相,表明发生了渐进性聚集。我们的研究结果表明,细胞内带负电荷物质或囊泡的富集诱导tau相分离,可能导致其病理性聚集。这些结果深入了解了tau蛋白病的分子机制,并突出了治疗干预的潜在靶点。